Cover Image

PAPERBACK
$63.25



View/Hide Left Panel

REFERENCES

Allison JE, Feldman R, Tekawa IS. 1990. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med. 112:328–333.

Allison JE, Tekawa IS, Ransom LJ, Adrain AL. 1996. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 334:155–159.

Arminski TC, McLean DW. 1964. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 7:249–261.


Blatt LJ. 1961. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum. 4:277–282.


Correa P, Strong JP, Reif A, Johnson WD. 1977. The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer. 39:2258–2264.

Behavioral risk factor surveillance system online prevalence data, 1995–2001. http://apps.nccd.cdc.gov/brfss; 5/5/2003.


Eide TJ, Stalsberg H. 1978. Polyps of the large intestine in Northern Norway. Cancer. 42:2839–2848.

Eide TJ. 1986. The age-, sex-, and site-specific occurrence of adenomas and carcinomas of the large intestine within a defined population. Scand J Gastroenterol. 21:1083–1088.


Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW et al. 1996. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 348:1472–1477.

Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M. 1996. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut. 132:449–456.


Koretz RL. 1993. Malignant polyps: are they sheep in wolves’ clothing? Ann Intern Med. 118:63–68.

Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. 1996. Randomised study of screening for colorectal cancer with faecal- occult-blood test. Lancet. 348:1467–1471.


Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. 1993. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 328:1365–1371.


Ness RM, Klein R, Holmes AM, Dittus R. 2000. At what age is one-time colonoscopic screening for colorectal cancer most cost-effective? Am J Gastroenterol. 95:1800–1811.


Schoen RE, Wissfeld JL, Trauth JM, Ling BS, Hayran M. 2002. A population-based, community estimate of total colon examination: the impact of compliance with screening for colorectal cancer. Am J Gastroenterol. 97:446–451.

SEER cancer incidence public-use database, 1973–93. 1996. Department of Health and Human Services: Bethesda, MD.

Sonnenberg A, Delco F, Inadomi JM. 2000. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 133:573–584.


Taplin SH, Barlow W, Urban N, Mandelson DJ, Ichikawa L, Nefcy P. 1995. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 87:417–426.


Vatn MH, Stalsberg H. 1982. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 49:819–825.


Williams AR, Balasooriya BAW, Day DW. 1982. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 23:835–842.

Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS et al. 1993. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 329:1977–1981.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement